NCT04205110

Brief Summary

Imaging the inside of coronary arteries (intravascular imaging) offers great insight into the assessment and treatment of coronary artery disease. Over time, substances such as fat, cholesterol and calcium can build up into 'plaques' in the arteries, causing narrowings or even blockages. These plaques can also rupture, causing cardiovascular events such as heart attacks or strokes. By using ultrasound and infrared technology, intravascular imaging can help assess these plaques, however this is an invasive technique involving angiography. Plaque composition, structure and stability can be affected by inflammation and the stress that the arteries are under. The investigators have pioneered novel minimally-invasive methods for modelling arterial stress using computed tomography coronary angiography (CTCA), as well as imaging coronary arterial inflammation using a positron emission tomography (PET) scan. Before embarking upon a large-scale clinical outcome study to determine whether these novel methods can improve risk prediction, the aim is to perform a proof-of-principle study to further develop our methodology for hybrid image analysis, and to validate this technique against high-resolution intravascular imaging as a surrogate marker of histology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 19, 2019

Completed
11 months until next milestone

Study Start

First participant enrolled

November 1, 2020

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2023

Completed
Last Updated

February 6, 2025

Status Verified

February 1, 2025

Enrollment Period

2.9 years

First QC Date

December 13, 2019

Last Update Submit

February 4, 2025

Conditions

Keywords

Intravascular UltrasoundNear Infrared SpectroscopyPositron Emission Tomography

Outcome Measures

Primary Outcomes (1)

  • Faesibility of co-registration of CTCA and PET-CT data

    All studied vessels will be dividen into 3 mm segments and the CTCA and PET-CT studies will be co-registered electronically. The faesibility of this will be reported

    12 months

Secondary Outcomes (4)

  • Comparing PET-CT, CTCA and intravascular imaging: plaque volume

    12 months

  • Comparing PET-CT, CTCA and intravascular imaging: plaque composition

    12 months

  • Comparing PET-CT, CTCA and intravascular imaging: haemodynamic forces

    12 months

  • Comparing PET-CT, CTCA and intravascular imaging: presence of inflammation

    12 months

Interventions

PET-CTDIAGNOSTIC_TEST

PET-CT compared to intravascular imaging for assessment of atherosclerotic plaques in stable angina patients

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Stable angina patients with known coronary artery disease referred for further invasive assessment as part of routine clincal care

You may qualify if:

  • Age ≥40
  • Stable angina, defined as typical symptoms with evidence of reversible ischemia in non-invasive test and/or documented obstructive coronary artery disease on coronary angiography
  • Patient that is willing and can provide written informed consent.

You may not qualify if:

  • Acute coronary syndrome within \<3 months
  • Pregnancy
  • Estimated glomerular filtration rate (eGFR) \<60ml/min/1.73m²
  • Previous bypass surgery
  • Decompensated heart failure, or left ventricular ejection fraction less than 30%
  • Patient allergic to contrast or cannot receive treatment with aspirin, heparin, or thienopyridines
  • Anticipated life expectancy \<2 years
  • Flow limiting coronary artery disease in the proximal segments of all the 3 epicardial coronaries
  • History of heart transplantation
  • Patient that requires surgical revascularization
  • Extensive coronary artery disease (i.e., multiple chronic total occlusions) or tortuous coronary anatomy that does not allow assessment of the

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Bartholomew's Hospital

London, EC1A 7BE, United Kingdom

Location

MeSH Terms

Conditions

Angina, StableCoronary Artery Disease

Interventions

Positron Emission Tomography Computed Tomography

Condition Hierarchy (Ancestors)

Angina PectorisMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCoronary DiseaseArteriosclerosisArterial Occlusive Diseases

Intervention Hierarchy (Ancestors)

Positron-Emission TomographyTomography, Emission-ComputedImage Interpretation, Computer-AssistedDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomography, X-Ray ComputedMultimodal ImagingRadiographic Image EnhancementImage EnhancementPhotographyRadiographyTomography, X-RayRadionuclide ImagingTomographyDiagnostic Techniques, Radioisotope

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2019

First Posted

December 19, 2019

Study Start

November 1, 2020

Primary Completion

October 10, 2023

Study Completion

October 10, 2023

Last Updated

February 6, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations